Ameliorate hepatic inflammation in NAFLD rats by blocking the TLR4/NF-κB/NLRP3 pathway, with multi-components and multi-targets action pattern. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.